Golotimod

戈洛莫德

Report date: 2022/09/14 17:12:36
NME

Base Information

Drug NameGolotimod
Drug Alias NamegolotimodumGamma-D-glutamyl-L-tryptophanSCV-07
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsStomatitisMucositisHead and Neck Neoplasms +[4] 
Global Approved IndicationsMucositisHepatitis C
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2009/01/01
Country/TerritoryUnited StatesRussian FederationMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesVerta
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSciclone PharmaceuticalsSciclone Pharmaceuticals Inc
Active IndicationsMucositisHepatitis C
Inactive IndicationsStomatitisHead and Neck Neoplasms

Other Information

ATC CodeA05A
Related LinksDrugBankKEGG